Concepts (250)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscle, Skeletal | 23 | 2024 | 464 | 4.480 |
Why?
|
| Annexin A6 | 6 | 2022 | 10 | 2.290 |
Why?
|
| Muscular Dystrophies | 7 | 2024 | 55 | 2.160 |
Why?
|
| Muscle Proteins | 8 | 2021 | 134 | 2.130 |
Why?
|
| Cell Membrane | 9 | 2021 | 669 | 2.030 |
Why?
|
| Membrane Proteins | 11 | 2021 | 1214 | 1.990 |
Why?
|
| Muscular Dystrophy, Duchenne | 8 | 2024 | 30 | 1.980 |
Why?
|
| Muscular Dystrophy, Animal | 8 | 2019 | 21 | 1.880 |
Why?
|
| Muscle Fibers, Skeletal | 6 | 2019 | 47 | 1.830 |
Why?
|
| Immunoglobulin G | 6 | 2023 | 466 | 1.780 |
Why?
|
| Muscular Dystrophies, Limb-Girdle | 5 | 2024 | 14 | 1.430 |
Why?
|
| Dysferlin | 6 | 2024 | 14 | 1.400 |
Why?
|
| Calcium | 4 | 2022 | 1170 | 1.210 |
Why?
|
| Muscle Development | 6 | 2019 | 41 | 1.170 |
Why?
|
| Dried Blood Spot Testing | 3 | 2021 | 10 | 1.130 |
Why?
|
| Vesicular Transport Proteins | 3 | 2015 | 63 | 1.060 |
Why?
|
| Muscles | 3 | 2024 | 193 | 1.010 |
Why?
|
| Vaccines, Synthetic | 2 | 2021 | 55 | 0.980 |
Why?
|
| Myoblasts | 7 | 2024 | 32 | 0.840 |
Why?
|
| Sarcolemma | 10 | 2019 | 31 | 0.840 |
Why?
|
| Sarcoglycans | 7 | 2024 | 14 | 0.830 |
Why?
|
| Membrane Fusion | 3 | 2021 | 37 | 0.810 |
Why?
|
| Mice | 26 | 2024 | 11707 | 0.800 |
Why?
|
| Neuromuscular Diseases | 1 | 2021 | 30 | 0.800 |
Why?
|
| Excitation Contraction Coupling | 1 | 2021 | 8 | 0.790 |
Why?
|
| Family Characteristics | 2 | 2022 | 49 | 0.780 |
Why?
|
| Serologic Tests | 2 | 2021 | 44 | 0.780 |
Why?
|
| Annexins | 2 | 2022 | 6 | 0.770 |
Why?
|
| Animals | 35 | 2024 | 27235 | 0.760 |
Why?
|
| Pandemics | 5 | 2023 | 759 | 0.720 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2010 | 114 | 0.690 |
Why?
|
| Gene Editing | 1 | 2019 | 44 | 0.680 |
Why?
|
| Exons | 3 | 2019 | 452 | 0.680 |
Why?
|
| Spike Glycoprotein, Coronavirus | 5 | 2022 | 44 | 0.670 |
Why?
|
| Antibodies, Viral | 6 | 2022 | 306 | 0.640 |
Why?
|
| Health Personnel | 1 | 2020 | 209 | 0.620 |
Why?
|
| Myocytes, Cardiac | 7 | 2024 | 312 | 0.590 |
Why?
|
| Muscle Cells | 1 | 2017 | 18 | 0.590 |
Why?
|
| Betacoronavirus | 1 | 2020 | 260 | 0.580 |
Why?
|
| Protein Transport | 8 | 2016 | 419 | 0.570 |
Why?
|
| Health | 1 | 2015 | 29 | 0.530 |
Why?
|
| Induced Pluripotent Stem Cells | 4 | 2024 | 112 | 0.510 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 318 | 0.510 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 303 | 0.510 |
Why?
|
| Neutralization Tests | 4 | 2022 | 79 | 0.500 |
Why?
|
| Disease | 1 | 2015 | 90 | 0.500 |
Why?
|
| Proteostasis | 2 | 2024 | 10 | 0.480 |
Why?
|
| Muscular Diseases | 3 | 2023 | 64 | 0.480 |
Why?
|
| Dynamin II | 1 | 2014 | 15 | 0.470 |
Why?
|
| Myopathies, Structural, Congenital | 1 | 2014 | 10 | 0.470 |
Why?
|
| Quadriceps Muscle | 1 | 2014 | 5 | 0.470 |
Why?
|
| Glycerol | 1 | 2013 | 35 | 0.460 |
Why?
|
| Glucocorticoids | 4 | 2023 | 358 | 0.440 |
Why?
|
| Actins | 1 | 2016 | 458 | 0.440 |
Why?
|
| Antibodies, Neutralizing | 3 | 2022 | 118 | 0.420 |
Why?
|
| Fibrosis | 4 | 2023 | 237 | 0.420 |
Why?
|
| Disease Models, Animal | 7 | 2024 | 2347 | 0.420 |
Why?
|
| Mice, Knockout | 6 | 2024 | 1987 | 0.420 |
Why?
|
| Gene Expression | 3 | 2019 | 1312 | 0.400 |
Why?
|
| Male | 17 | 2024 | 42020 | 0.380 |
Why?
|
| Antibody Formation | 2 | 2021 | 171 | 0.380 |
Why?
|
| Seroepidemiologic Studies | 2 | 2021 | 55 | 0.380 |
Why?
|
| RNA, Messenger | 3 | 2019 | 2009 | 0.370 |
Why?
|
| Mice, 129 Strain | 3 | 2021 | 57 | 0.370 |
Why?
|
| NFATC Transcription Factors | 1 | 2010 | 49 | 0.360 |
Why?
|
| Latent TGF-beta Binding Proteins | 2 | 2021 | 4 | 0.360 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2009 | 45 | 0.350 |
Why?
|
| DNA | 1 | 2015 | 1308 | 0.350 |
Why?
|
| Wound Healing | 4 | 2016 | 356 | 0.340 |
Why?
|
| Prednisone | 3 | 2019 | 258 | 0.340 |
Why?
|
| Female | 14 | 2024 | 45769 | 0.320 |
Why?
|
| Extracellular Matrix | 3 | 2024 | 245 | 0.310 |
Why?
|
| Humans | 27 | 2024 | 88633 | 0.300 |
Why?
|
| Carrier Proteins | 3 | 2021 | 679 | 0.290 |
Why?
|
| Young Adult | 4 | 2021 | 6220 | 0.270 |
Why?
|
| Vaccination | 3 | 2023 | 270 | 0.260 |
Why?
|
| Regeneration | 3 | 2017 | 149 | 0.250 |
Why?
|
| Cells, Cultured | 6 | 2018 | 2880 | 0.250 |
Why?
|
| Immunoblotting | 2 | 2016 | 274 | 0.240 |
Why?
|
| Filamins | 1 | 2024 | 22 | 0.240 |
Why?
|
| Cardiomyopathies | 2 | 2024 | 260 | 0.240 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2024 | 44 | 0.230 |
Why?
|
| Middle Aged | 6 | 2023 | 25710 | 0.230 |
Why?
|
| Myocarditis | 1 | 2024 | 52 | 0.230 |
Why?
|
| Mice, Inbred DBA | 6 | 2024 | 150 | 0.230 |
Why?
|
| Adult | 6 | 2024 | 26357 | 0.230 |
Why?
|
| Mice, Mutant Strains | 2 | 2016 | 231 | 0.220 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2015 | 311 | 0.210 |
Why?
|
| Mice, Inbred mdx | 4 | 2019 | 11 | 0.210 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2015 | 289 | 0.210 |
Why?
|
| Mice, Transgenic | 4 | 2022 | 1571 | 0.210 |
Why?
|
| Calcium-Binding Proteins | 2 | 2021 | 121 | 0.210 |
Why?
|
| Immunologic Tests | 1 | 2021 | 6 | 0.200 |
Why?
|
| Monocytes | 1 | 2023 | 217 | 0.200 |
Why?
|
| Nerve Tissue Proteins | 2 | 2015 | 511 | 0.200 |
Why?
|
| Drug Interactions | 1 | 2021 | 248 | 0.190 |
Why?
|
| Extracellular Vesicles | 1 | 2022 | 43 | 0.190 |
Why?
|
| Heart Diseases | 1 | 2023 | 297 | 0.190 |
Why?
|
| Cell Differentiation | 2 | 2024 | 1518 | 0.190 |
Why?
|
| Steroids | 1 | 2021 | 175 | 0.180 |
Why?
|
| Genes, Modifier | 2 | 2017 | 5 | 0.180 |
Why?
|
| Immunity, Innate | 1 | 2024 | 427 | 0.180 |
Why?
|
| Muscle Contraction | 1 | 2021 | 284 | 0.180 |
Why?
|
| Cell Movement | 1 | 2024 | 784 | 0.180 |
Why?
|
| Mice, Inbred C57BL | 5 | 2016 | 3195 | 0.180 |
Why?
|
| Chicago | 2 | 2021 | 1411 | 0.170 |
Why?
|
| Lysosomes | 2 | 2010 | 109 | 0.170 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 379 | 0.170 |
Why?
|
| Myotonic Dystrophy | 1 | 2019 | 7 | 0.170 |
Why?
|
| Transforming Growth Factor beta | 1 | 2021 | 322 | 0.170 |
Why?
|
| MyoD Protein | 1 | 2019 | 15 | 0.170 |
Why?
|
| Dual Specificity Phosphatase 6 | 1 | 2019 | 1 | 0.170 |
Why?
|
| Point Mutation | 1 | 2019 | 246 | 0.160 |
Why?
|
| Signal Transduction | 1 | 2009 | 3371 | 0.160 |
Why?
|
| Sarcoglycanopathies | 1 | 2018 | 2 | 0.160 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2019 | 123 | 0.160 |
Why?
|
| Morpholinos | 1 | 2018 | 13 | 0.160 |
Why?
|
| Dystrophin | 4 | 2024 | 22 | 0.160 |
Why?
|
| Adolescent | 2 | 2021 | 9161 | 0.150 |
Why?
|
| Osteopontin | 1 | 2017 | 47 | 0.150 |
Why?
|
| Protein Binding | 4 | 2022 | 1484 | 0.150 |
Why?
|
| Recombinant Proteins | 1 | 2019 | 1020 | 0.150 |
Why?
|
| Phospholipids | 1 | 2017 | 111 | 0.140 |
Why?
|
| Genetic Therapy | 2 | 2018 | 369 | 0.140 |
Why?
|
| Sensitivity and Specificity | 1 | 2021 | 2019 | 0.140 |
Why?
|
| Microscopy, Fluorescence | 2 | 2018 | 428 | 0.140 |
Why?
|
| Exosomes | 1 | 2017 | 53 | 0.140 |
Why?
|
| Cell Communication | 1 | 2017 | 198 | 0.140 |
Why?
|
| Dystrophin-Associated Protein Complex | 1 | 2015 | 3 | 0.130 |
Why?
|
| Electroporation | 1 | 2015 | 57 | 0.130 |
Why?
|
| Transcription Factors | 1 | 2024 | 1649 | 0.130 |
Why?
|
| Base Sequence | 1 | 2019 | 2331 | 0.130 |
Why?
|
| Creatine Kinase | 1 | 2015 | 52 | 0.130 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2015 | 68 | 0.130 |
Why?
|
| Luminescent Proteins | 1 | 2015 | 144 | 0.130 |
Why?
|
| Plasmids | 1 | 2015 | 292 | 0.130 |
Why?
|
| Intracellular Space | 2 | 2014 | 38 | 0.120 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 275 | 0.120 |
Why?
|
| Protein Engineering | 1 | 2015 | 141 | 0.120 |
Why?
|
| Heterozygote | 1 | 2015 | 371 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2024 | 2324 | 0.120 |
Why?
|
| Fluorescent Dyes | 1 | 2015 | 243 | 0.120 |
Why?
|
| Cell Adhesion | 1 | 2015 | 425 | 0.120 |
Why?
|
| Cohort Studies | 1 | 2021 | 2837 | 0.120 |
Why?
|
| Caveolin 3 | 1 | 2014 | 4 | 0.120 |
Why?
|
| Cell Line | 4 | 2024 | 2498 | 0.120 |
Why?
|
| HIV Infections | 1 | 2023 | 829 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 927 | 0.110 |
Why?
|
| Aged | 2 | 2021 | 18939 | 0.110 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2013 | 135 | 0.110 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 386 | 0.110 |
Why?
|
| Cell Survival | 1 | 2015 | 980 | 0.110 |
Why?
|
| Endosomes | 2 | 2010 | 79 | 0.110 |
Why?
|
| Cytoskeleton | 1 | 2014 | 194 | 0.110 |
Why?
|
| MicroRNAs | 1 | 2017 | 551 | 0.100 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2010 | 5 | 0.100 |
Why?
|
| Gene Expression Regulation | 3 | 2019 | 1976 | 0.090 |
Why?
|
| Cardiotoxins | 1 | 2010 | 3 | 0.090 |
Why?
|
| Lysosomal-Associated Membrane Protein 2 | 1 | 2009 | 4 | 0.090 |
Why?
|
| Myoblasts, Skeletal | 1 | 2009 | 3 | 0.090 |
Why?
|
| Myofibrils | 1 | 2009 | 23 | 0.090 |
Why?
|
| Calcium Signaling | 1 | 2010 | 138 | 0.090 |
Why?
|
| Models, Animal | 1 | 2010 | 276 | 0.080 |
Why?
|
| Models, Biological | 1 | 2015 | 1765 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 2399 | 0.070 |
Why?
|
| Endocytosis | 1 | 2008 | 180 | 0.070 |
Why?
|
| RNA Splicing | 2 | 2019 | 150 | 0.070 |
Why?
|
| HEK293 Cells | 2 | 2022 | 637 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 956 | 0.070 |
Why?
|
| Lamin Type A | 1 | 2006 | 26 | 0.070 |
Why?
|
| Annexin A2 | 1 | 2024 | 2 | 0.060 |
Why?
|
| Decorin | 1 | 2024 | 6 | 0.060 |
Why?
|
| Cell Nucleus | 1 | 2006 | 594 | 0.060 |
Why?
|
| Bortezomib | 1 | 2024 | 82 | 0.060 |
Why?
|
| Mutation | 3 | 2024 | 4100 | 0.060 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2024 | 136 | 0.060 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2024 | 195 | 0.050 |
Why?
|
| Quantitative Trait Loci | 2 | 2019 | 606 | 0.050 |
Why?
|
| Stress, Physiological | 1 | 2024 | 231 | 0.050 |
Why?
|
| A549 Cells | 1 | 2022 | 41 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2006 | 726 | 0.050 |
Why?
|
| Vero Cells | 1 | 2022 | 101 | 0.050 |
Why?
|
| Proteomics | 1 | 2023 | 228 | 0.050 |
Why?
|
| Antibodies, Blocking | 1 | 2021 | 21 | 0.050 |
Why?
|
| Immunoassay | 1 | 2021 | 92 | 0.050 |
Why?
|
| HeLa Cells | 1 | 2022 | 507 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 2 | 2015 | 741 | 0.050 |
Why?
|
| Anacardic Acids | 1 | 2019 | 1 | 0.040 |
Why?
|
| Pulse Therapy, Drug | 1 | 2019 | 2 | 0.040 |
Why?
|
| MEF2 Transcription Factors | 1 | 2019 | 9 | 0.040 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2023 | 305 | 0.040 |
Why?
|
| Histone Acetyltransferases | 1 | 2019 | 42 | 0.040 |
Why?
|
| Residence Characteristics | 1 | 2021 | 196 | 0.040 |
Why?
|
| Genetic Variation | 2 | 2019 | 1369 | 0.040 |
Why?
|
| Metabolomics | 1 | 2019 | 73 | 0.040 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2019 | 98 | 0.040 |
Why?
|
| Epigenomics | 1 | 2019 | 103 | 0.040 |
Why?
|
| Disease Progression | 1 | 2023 | 1490 | 0.040 |
Why?
|
| Reading Frames | 1 | 2018 | 6 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2018 | 76 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2022 | 1542 | 0.040 |
Why?
|
| Cellular Reprogramming | 1 | 2018 | 41 | 0.040 |
Why?
|
| Annexin A1 | 1 | 2017 | 5 | 0.040 |
Why?
|
| Urine | 1 | 2018 | 90 | 0.040 |
Why?
|
| Transduction, Genetic | 1 | 2018 | 160 | 0.040 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2017 | 45 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2019 | 799 | 0.040 |
Why?
|
| Mutation, Missense | 1 | 2019 | 276 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2017 | 105 | 0.040 |
Why?
|
| Muscular Atrophy | 1 | 2017 | 43 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2019 | 258 | 0.040 |
Why?
|
| Transcriptional Activation | 1 | 2017 | 290 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2017 | 291 | 0.030 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2017 | 131 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2019 | 1077 | 0.030 |
Why?
|
| Codon, Nonsense | 1 | 2015 | 42 | 0.030 |
Why?
|
| Diaphragm | 1 | 2015 | 50 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 502 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2017 | 902 | 0.030 |
Why?
|
| Protein Interaction Mapping | 1 | 2015 | 82 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2015 | 205 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2018 | 755 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 2746 | 0.030 |
Why?
|
| Abdominal Muscles | 1 | 2014 | 19 | 0.030 |
Why?
|
| Membranes | 1 | 2014 | 36 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 1694 | 0.030 |
Why?
|
| Chromosomes, Mammalian | 1 | 2014 | 36 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2015 | 565 | 0.030 |
Why?
|
| Organ Size | 1 | 2014 | 369 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2014 | 199 | 0.030 |
Why?
|
| Biomarkers | 1 | 2019 | 1756 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2014 | 210 | 0.030 |
Why?
|
| Myocardium | 1 | 2015 | 570 | 0.030 |
Why?
|
| Time Factors | 1 | 2021 | 5320 | 0.030 |
Why?
|
| Drosophila melanogaster | 1 | 2015 | 605 | 0.020 |
Why?
|
| Drosophila Proteins | 1 | 2015 | 498 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2010 | 559 | 0.020 |
Why?
|
| Heart Ventricles | 1 | 2014 | 779 | 0.020 |
Why?
|
| Transferrin | 1 | 2008 | 19 | 0.020 |
Why?
|
| Cell Fusion | 1 | 2008 | 39 | 0.020 |
Why?
|
| Child | 1 | 2019 | 7090 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2008 | 211 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2008 | 353 | 0.020 |
Why?
|
| Nuclear Envelope | 1 | 2006 | 38 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2006 | 95 | 0.020 |
Why?
|
| Hydroxyproline | 1 | 2005 | 11 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2008 | 2062 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2008 | 1295 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2008 | 3029 | 0.010 |
Why?
|
| Motor Activity | 1 | 2005 | 328 | 0.010 |
Why?
|